These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8143299)

  • 1. Nitric oxide and cardioprotection during ischemia-reperfusion.
    Jugdutt BI
    Heart Fail Rev; 2002 Oct; 7(4):391-405. PubMed ID: 12379824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the renin-angiotensin system after acute myocardial infarction--treat first, select later?
    Hall AS; Sapsford R; Megarry SG; Ball SG
    Heart; 1996 Nov; 76(3 Suppl 3):73-8. PubMed ID: 8977366
    [No Abstract]   [Full Text] [Related]  

  • 3. Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure.
    Frampton JE; Peters DH
    Drugs; 1995 Mar; 49(3):440-66. PubMed ID: 7774515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G; Vecchio C
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibitors in heart failure: what more do we need to know?
    Demers C; Mody A; Teo KK; McKelvie RS
    Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ACE/kininase-II, acute myocardial infarction, and survival.
    Hall AS; Tan LB; Ball SG
    Cardiovasc Res; 1994 Feb; 28(2):190-8. PubMed ID: 8143299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction?
    Ball SG; Hall AS
    Am Heart J; 1996 Jul; 132(1 Pt 2 Su):244-50. PubMed ID: 8677863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.